EDGAR Filing Documents for 0001104659-17-057953

Form 4 - Statement of changes in beneficial ownership of securities:

SEC Accession No. 0001104659-17-057953

Filing Date

2017-09-19

Accepted

2017-09-19 21:31:37

Documents

Period of Report

2017-09-15

Document Format Files

Seq	Description	Document	Type	Size
1	4	a4.html	4
1	4	a4.xml	4	3951
	Complete submission text file	0001104659-17-057953.txt		5438

Mailing Address C/O DURATA THERAPEUTICS, INC. 89 HEADQUARTERS PLAZA NORTH, 14TH FLOOR MORRISTOWN NJ 07960

Business Address

Type: 4 | Act: 34 | File No.: 001-37558 | Film No.: 171093165

Mailing Address 1000 CONTINENTAL DRIVE SUITE 600 KING OF PRUSSIA PA 19406

Business Address 56 FITZWILLIAM SQUARE DUBLIN L2 2 (610) 816-6640

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations